ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1833

Immune Complexes of Antibodies Directed to Angiotensin Receptor type-1 and Extracellular Vesicles Are Unique Modulators Contributing to Systemic Sclerosis

Alexander Maximilian Hackel1, Marieke Leiber1, Maike Winziers1, Gabriela Riemekasten2 and Reza Akbarzadeh1, 1Department of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, Germany, 2University of Lübeck, Department of Rheumatology and Clinical Immunology, Lübeck, Germany

Meeting: ACR Convergence 2024

Keywords: Autoantibody(ies), autoimmune diseases, Systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Antibodies (Abs) directed against the angiotensin II type-1 receptor (AT1R) and extracellular vesicles (EVs) derived from systemic sclerosis (SSc) patients have the potential to modulate the function of monocytes, which are key cells in SSc pathogenesis. This study aims to investigate whether AT1R Abs interacts with EVs and to determine the phenotype and function of monocytes, particularly their migration capacity and cytokine secretion.

Methods: Exosomes were isolated from the sera of SSc patients and healthy controls (HC) using sequential centrifugation and precipitation via polyethylene glycol. The size of the EVs was analyzed by nanoparticle tracking analysis. AT1R expression on EVs was analyzed by western blot. To study the phenotype and function of monocytes induced by EVs and AT1R Abs, human peripheral blood (PB) monocytes from HC were stimulated either with a self-engineered activating monoclonal AT1R Abs (AT1R mab) alone or preincubated with EVs from SSc patients or HC. The expression of surface molecules on the monocytes was analyzed by flow cytometry and compared with the monocyte phenotype derived from SSc patients. Monocytic cytokine expression was studied using ELISA and a cytokine array. Monocyte migration was assessed using trans-well and organ-on-a-chip assays.

Results: Compared to EVs from HC, those derived from SSc patients showed a higher abundance of AT1R, facilitating antibody binding. In SSc, high AT1R antibody levels go along with reduced EV diameters. Preincubation of SSc-EVs with AT1R mab resulted in pro-inflammatory and pro-fibrotic monocyte activation, as evidenced by secretome analysis and increased secretion of pro-fibrotic CCL18 (Figure 1A). The secretome induced by the combination of EVs and mAT1R Abs was distinct from that induced by either EVs or mAT1R Abs alone. Notably, SSc EVs preincubated with mAT1R Abs induced a significant change in the monocyte cell line phenotype, resulting in an intermediate-like phenotype (Figure 1B). This same phenotype was observed in monocytes from patients with diffuse SSc. Migration of monocytes was significantly increased by both mAT1R Abs and EVs from SSc patients, but not by EVs from HC or by applying an isotype control.

Conclusion: Our study demonstrated that mAT1R ab, EVs, and particularly EV-immune complexes induce a unique phenotype of monocytes. EVs are not only distributing mAT1R abs but also contributing to immune cell migration and induction of fibrosis. This study further supports the specific contribution of AT1R ab-mediated processes in SSc.

Supporting image 1


Disclosures: A. Hackel: None; M. Leiber: None; M. Winziers: None; G. Riemekasten: CellTrend GmbH, 1; R. Akbarzadeh: None.

To cite this abstract in AMA style:

Hackel A, Leiber M, Winziers M, Riemekasten G, Akbarzadeh R. Immune Complexes of Antibodies Directed to Angiotensin Receptor type-1 and Extracellular Vesicles Are Unique Modulators Contributing to Systemic Sclerosis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/immune-complexes-of-antibodies-directed-to-angiotensin-receptor-type-1-and-extracellular-vesicles-are-unique-modulators-contributing-to-systemic-sclerosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/immune-complexes-of-antibodies-directed-to-angiotensin-receptor-type-1-and-extracellular-vesicles-are-unique-modulators-contributing-to-systemic-sclerosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology